The economic burden of cancer is substantial, affecting individuals, families, and healthcare systems. Costs include direct medical expenses for treatment and care, and indirect costs from lost productivity and income. High-income countries often bear higher economic costs due to advanced treatment options, whereas low- and middle-income countries face challenges in affording even basic care, exacerbating health disparities.
